Home
About
Overview
Sharing Data
ORCID
Help
History (38)
DAS181 for Treatment of Parainfluenza Virus Infections in Hematopoietic Stem Cell Transplant Recipients at a Single Center.
A double-blind, randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder.
Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86).
Intravitreal Injections: Minimizing the Risk and Maximizing Comfort.
MN1 C-terminal truncation syndrome is a novel neurodevelopmental and craniofacial disorder with partial rhombencephalosynapsis.
See All 38 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
MN1 C-terminal truncation syndrome is a novel neurodevelopmental and craniofacial disorder with partial rhombencephalosynapsis.
MN1 C-terminal truncation syndrome is a novel neurodevelopmental and craniofacial disorder with partial rhombencephalosynapsis. Brain. 2020 01 01; 143(1):55-68.
View in:
PubMed
subject areas
Abnormalities, Multiple
Adolescent
Basilar Artery
Carotid Arteries
Cerebellar Vermis
Cerebellum
Child
Child, Preschool
Cohort Studies
Comparative Genomic Hybridization
Craniofacial Abnormalities
Female
Fibroblasts
Humans
Imaging, Three-Dimensional
Infant
Intellectual Disability
Language Development Disorders
Magnetic Resonance Imaging
Male
Middle Aged
Mutation
Nervous System Malformations
Nonsense Mediated mRNA Decay
Polymicrogyria
Real-Time Polymerase Chain Reaction
Syndrome
Tomography, X-Ray Computed
Trans-Activators
Tumor Suppressor Proteins
Whole Genome Sequencing
authors with profiles
Russell Reid
William B. Dobyns